p300 Acetylates JHDM1A to inhibit osteosarcoma carcinogenesis

References

• Harrison DJ, Geller DS, Gill JD, et al. Current and future therapeutic approaches for osteosarcoma. Expert Rev Anticancer Ther. 2018;18:39–50.
   PubMed Web of Science ®Google Scholar
• Chrun ES, Modolo F, Daniel FI. Histone modifications: a review about the presence of this epigenetic phenomenon in carcinogenesis. Pathol Res Pract. 2017;213:1329–1339.
   PubMed Web of Science ®Google Scholar
• Vaidya H, Rumph C, Katula KS. Inactivation of the WNT5A alternative promoter B is associated with DNA methylation and histone modification in osteosarcoma cell lines U2OS and SaOS-2. PLOS One. 2016;11:e0151392.
   PubMed Web of Science ®Google Scholar
• La Noce M, Paino F, Mele L, et al. HDAC2 depletion promotes osteosarcoma's stemness both in vitro and in vivo: a study on a putative new target for CSCs directed therapy. J Exp Clin Cancer Res. 2018;3;37:296.
   Web of Science ®Google Scholar
• Kelso TWR, Porter DK, Amaral ML, et al. Chromatin accessibility underlies synthetic lethality of SWI/SNF subunits in ARID1A-mutant cancers. Elife. 2017;6:pii:e30506.
   Web of Science ®Google Scholar
• Soci UPR, Melo SFS, Gomes JLP, et al. Exercise training and epigenetic regulation: multilevel modification and regulation of gene expression. Adv Exp Med Biol. 2017;1000:281–322.
   PubMed Web of Science ®Google Scholar
• Brennecke P, Arlt MJ, Campanile C, et al. CXCR4 antibody treatment suppresses metastatic spread to the lung of intratibial human osteosarcoma xenografts in mice. Clin Exp Metastasis. 2014;31:339–349.
   PubMed Web of Science ®Google Scholar
• Peng YB, Fan B, Han XL, et al. Molecular characterization of the porcine JHDM1A gene associated with average daily gain: evaluation its role in skeletal muscle development and growth. Mol Biol Rep. 2011;38:4697–4704.
   PubMed Web of Science ®Google Scholar
• Fnu S, Williamson EA, De Haro LP, et al. Methylation of histone H3 lysine 36 enhances DNA repair by nonhomologous end-joining. Proc Natl Acad Sci USA. 2011;108:540–545.
   PubMed Web of Science ®Google Scholar
• Dhar SS, Alam H, Li N, et al. Transcriptional repression of histone deacetylase 3 by the histone demethylase KDM2A is coupled to tumorigenicity of lung cancer cells. J Biol Chem. 2014;289:7483–7496.
   PubMed Web of Science ®Google Scholar
• Hsia DA, Tepper CG, Pochampalli MR, et al. KDM8, a H3K36me2 histone demethylase that acts in the cyclin A1 coding region to regulate cancer cell proliferation. Proc Natl Acad Sci USA. 2010;107:9671–9676.
   PubMed Web of Science ®Google Scholar
• Sankaran SM, Gozani O. Characterization of H3.3K36M as a tool to study H3K36 methylation in cancer cells. Epigenetics. 2017;12:917–922.
   PubMed Web of Science ®Google Scholar
• Tanaka Y, Yano H, Ogasawara S, et al. Mild glucose starvation induces KDM2A-mediated H3K36me2 demethylation through AMPK to reduce rRNA transcription and cell proliferation. Mol Cell Biol. 2015;35:4170–4184.
   PubMed Web of Science ®Google Scholar
• Varier RA, Timmers HT. Histone lysine methylation and demethylation pathways in cancer. Biochim Biophys Acta. 2011;1815:75–89.
   PubMed Web of Science ®Google Scholar
• Wagner KW, Alam H, Dhar SS, et al. KDM2A promotes lung tumorigenesis by epigenetically enhancing ERK1/2 signaling. J Clin Invest. 2013;123:5231–5246.
   PubMed Web of Science ®Google Scholar
• Lu DH, Yang J, Gao LK, et al. Lysine demethylase 2A promotes the progression of ovarian cancer by regulating the PI3K pathway and reversing epithelial mesenchymal transition. Oncol Rep. 2019;41:917–927.
   PubMed Web of Science ®Google Scholar
• Chen J, Ghazawi FM, Li Q. Interplay of bromodomain and histone acetylation in the regulation of p300-dependent genes. Epigenetics. 2010;5:509–515.
   PubMed Web of Science ®Google Scholar
• Holmqvist PH, Mannervik M. Genomic occupancy of the transcriptional co-activators p300 and CBP. Transcription. 2013;4:18–23.
   PubMedGoogle Scholar
• Luo H, Shenoy AK, Li X, et al. MOF acetylates the histone demethylase LSD1 to suppress epithelial-to-mesenchymal transition. Cell Rep. 2016;15:2665–2678.
   PubMed Web of Science ®Google Scholar
• Ish-Shalom S, Lichter A. Analysis of fungal gene expression by real time quantitative PCR. Methods Mol Biol. 2010;638:103–114.
   PubMedGoogle Scholar
• Machida K, Liu B. Binding assays using recombinant SH2 domains: far-western, pull-down, and fluorescence polarization. Methods Mol Biol (Clifton, NJ). 2017;1555:307–330.
   PubMedGoogle Scholar
• Morera L, Lubbert M, Jung M. Targeting histone methyltransferases and demethylases in clinical trials for cancer therapy. Clin Epigenet. 2016;8:57.
   PubMed Web of Science ®Google Scholar
• Rizwani W, Schaal C, Kunigal S, et al. Mammalian lysine histone demethylase KDM2A regulates E2F1-mediated gene transcription in breast cancer cells. PLOS One. 2014;9:e100888.
   PubMed Web of Science ®Google Scholar
• Huang Y, Liu Y, Yu L, et al. Histone demethylase KDM2A promotes tumor cell growth and migration in gastric cancer. Tumor Biol. 2015;36:271–278.
   PubMedGoogle Scholar
• Rajabi HN, Baluchamy S, Kolli S, et al. Effects of depletion of CREB-binding protein on c-Myc regulation and cell cycle G1-S transition. J Biol Chem. 2005;280:361.
   PubMed Web of Science ®Google Scholar
• Sankar N, Kadeppagari RK, Thimmapaya B. c-Myc-induced aberrant DNA synthesis and activation of DNA damage response in p300 knockdown cells. J Biol Chem. 2009;284:15193–15205.
   PubMed Web of Science ®Google Scholar
• Wan W, You Z, Xu Y, et al. mTORC1 Phosphorylates acetyltransferase p300 to regulate autophagy and lipogenesis. Mol Cell. 2017;68:323–335.e6.
   PubMed Web of Science ®Google Scholar
• Sandberg ML, Sutton SE, Pletcher MT, et al. c-Myb and p300 regulate hematopoietic stem cell proliferation and differentiation. Dev Cell. 2005;8:153–166.
   PubMed Web of Science ®Google Scholar
• Gao XN, Lin J, Ning QY, et al. A histone acetyltransferase p300 inhibitor C646 induces cell cycle arrest and apoptosis selectively in AML1-ETO-positive AML cells. PLOS One. 2013;8:e55481.
   PubMed Web of Science ®Google Scholar
• Suganuma T, Ikeda MA. Tumor growth suppression by the coactivator p300. J Oral Biosci. 2008;50:115–124.
   Google Scholar
• Cho YA, Hong JS, Choe EJ, et al. The role of p300 in the tumor progression of oral squamous cell carcinoma. J Oral Pathol Med. 2015;44:185–192.
   PubMed Web of Science ®Google Scholar
• Sui Y, Han Y, Zhao X, et al. Long non-coding RNA GClnc1 promotes tumorigenesis in osteosarcoma by inhibiting p53 signaling. Biochem Biophys Res Comm. 2018;507:36–42.
   PubMed Web of Science ®Google Scholar
• Amendola PG, Zaghet N, Ramalho JJ, et al. JMJD-5/KDM8 regulates H3K36me2 and is required for late steps of homologous recombination and genome integrity. PLOS Genet. 2017;13:e1006632.
   PubMed Web of Science ®Google Scholar
• Zheng Q, Fan H, Meng Z, et al. Histone demethylase KDM2B promotes triple negative breast cancer proliferation by suppressing p15INK4B, p16INK4A, and p57KIP2 transcription. Acta Biochim Biophys Sinica. 2018;50:897–904.
   PubMed Web of Science ®Google Scholar
• He J, Nguyen AT, Zhang Y. KDM2b/JHDM1b, an H3K36me2-specific demethylase, is required for initiation and maintenance of acute myeloid leukemia. Blood. 2011;117:3869–3880.
   PubMed Web of Science ®Google Scholar
• Parveen A, Akash MS, Rehman K, et al. Dual role of p21 in the progression of cancer and its treatment. Crit Rev Eukaryot Gene Expr. 2016;26:49–62.
   PubMed Web of Science ®Google Scholar
• Yang J, Zhao X, Tang M, et al. The role of ROS and subsequent DNA-damage response in PUMA-induced apoptosis of ovarian cancer cells. Oncotarget. 2017;8:23492–23506.
   PubMedGoogle Scholar
• Woo TG, Yoon MH, Hong SD, et al. Anti-cancer effect of novel PAK1 inhibitor via induction of PUMA-mediated cell death and p21-mediated cell cycle arrest. Oncotarget. 2017;8:23690–23701.
   PubMedGoogle Scholar
• Ruan J, Zheng L, Hu N, et al. Long noncoding RNA SNHG6 promotes osteosarcoma cell proliferation through regulating p21 and KLF2. Arch Biochem Biophys. 2018;646:128–136.
   PubMed Web of Science ®Google Scholar
• Jiang K, Zhang C, Yu B, et al. Autophagic degradation of FOXO3a represses the expression of PUMA to block cell apoptosis in cisplatin-resistant osteosarcoma cells. Am J Cancer Res. 2017;7:1407–1422.
   PubMed Web of Science ®Google Scholar